Barely Significant
← all excerpts

Flutamide versus a cyproterone acetate-ethinyl estradiol combination in moderate acne: a pilot randomized clinical trial.

Clin Cosmet Investig Dermatol · 2011 · PMC3149479 · PMID 21833162

Europe PMCDOI
2
hedged sentences
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

a decreasing trendP < 0.001actually significant
The amount of sebum showed a decreasing trend overall (within-group P < 0.001) and prominently for the flutamide group (β = −4.3; between-group P < 0.01).

also in 47,180 other papers

showed a trendno p-value reported
In a descriptive sense, as shown in Figure 2 , the ASI and GAGS scores showed a trend of improvement in the flutamide group versus the cyproterone-estradiol combination group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.